ARCT as of Oct 31 · 19:36 ET
ARCTNasdaqPharmaceutical Preparations
Arcturus Therapeutics Holdings Inc. · Brief
Next report
9 days
Nov 9 · after closeest.Q3 FY26
Expected move
Inputs2 of 8≥ implied
- avg implied
- ±14.0%
- avg realized
- ±9.7%
Nov 7 '24±10.9%▲+4.72%×0.43
Mar 6 '25±14.7%▼−8.89%×0.60
May 12 '25±9.5%▲+2.33%×0.24
Aug 11 '25±10.2%▲+30.73%×3.03
Q3 FY25±10.9%▼−1.25%×0.11
Q1 FY26±18.3%▼−4.17%×0.23
May 7 '26±15.5%▲+3.60%×0.23
Q2 FY26±21.8%▲+21.88%×1.00
quarterimplied−35%0+35%realized×
Q2 FY26±21.8%▲+21.88%×1.00
May '26±15.5%▲+3.60%×0.23
Q1 FY26±18.3%▼−4.17%×0.23
Q3 FY25±10.9%▼−1.25%×0.11
Aug '25±10.2%▲+30.73%×3.03
May '25±9.5%▲+2.33%×0.24
2 older reports
Mar '25±14.7%▼−8.89%×0.60
Nov '24±10.9%▲+4.72%×0.43
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2 of 3
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
ARCT report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.